3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Tumor-Agnostic
2
Conditions
Neoplasms
2
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Second Primary
1
Interventions
pembrolizumab
38
Blood Specimen Collection
38
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
17
Exercise
17
Carboplatin
17
Nivolumab
15
atezolizumab
14
Paclitaxel
14
Cisplatin
14
Drug Therapy
13
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
11
Trastuzumab
10
Pemetrexed
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Registries
×
Clear all
NCT04511806
2025-10-29
CCPS
Emory University
Recruiting
1,050 enrolled
NCT02070328
2023-02-08
Registry
Center for Biomedical Research, LLC
Recruiting
300 enrolled